Table 1.
Demographics | NSBB (n=89) | Non-NSBB (n=49) | P value |
Sex (%) | 0.39 | ||
Male | 64 (71.9) | 31 (63.3) | |
Female | 25 (28.1) | 18 (36.7) | |
Age (years) (IQR) | 58 (49–66) | 59 (52–67) | 0.47 |
Main aetiology (%) | 0.52 | ||
Alcohol | 48 (53.9) | 31 (63.3) | |
Hepatitis C | 16 (18.0) | 7 (14.3) | |
Non-alcoholic steatohepatitis | 6 (6.7) | 6 (12.2) | |
Disease severity (IQR) | |||
Child-Pugh Score | 8 (8–10) | 8 (7–10) | 0.39 |
Model For End-Stage Liver Disease score | 13.50 (11.40–15.80) | 11.80 (9.40–14.40) | 0.006 |
Ascites (%) | |||
None | 38 (42.7) | 17 (34.7) | 0.12 |
Mild | 24 (27.0) | 9 (18.4) | |
Moderate | 18 (20.2) | 11 (22.4) | |
Severe | 9 (10.1) | 12 (24.5) | |
Hepatic encephalopathy (%) | 24 (27.0) | 10 (20.4) | 0.52 |
Hepatocellular carcinoma (%) | 6 (6.7) | 1 (2.0) | 0.42 |
Laboratory parameters (IQR) | |||
Sodium (mmol/L) | 137 (133–139) | 137 (135–138) | 0.91 |
Creatinine (μmol/L) | 70 (62–84) | 63 (57–73) | 0.03 |
Albumin (g/L) | 29 (25–33) | 30 (26–33) | 0.33 |
Bilirubin (µmol/L) | 39 (23–59) | 30 (15–52) | 0.06 |
International normalised ratio | 1.3 (1.2–1.5) | 1.3 (1.2–1.4) | 0.03 |
Platelets (×109/L) | 96 (66–144) | 127 (83–136) | 0.03 |
NSBB, non-selective beta blocker.